Has FDG PET/CT an impact on the management of patients with anal carcinoma?

被引：1

作者：

Vercellino, L. ^{[1
]}

de Parades, V. ^{[2
]}

Nataf, V. ^{[1
]}

Kerrou, K. ^{[1
]}

Huchet, V. ^{[1
]}

Bauer, P. ^{[2
]}

Pascal, O. ^{[1
]}

Touboul, E. ^{[3
]}

Montravers, F. ^{[1
]}

Talbot, J. -N. ^{[1
]}

机构：

[1] Univ Paris 06, Hop Tenon, Nucl Med Serv, F-75020 Paris 20, France

[2] Grp Hosp Diaconesses Croix St Simon, Serv Proctol Med Interventionnelle, F-75012 Paris, France

[3] Univ Paris 06, Hop Tenon, Serv Oncol Radiotherapie, F-75020 Paris 20, France

来源：

MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2010年 / 34卷 / 02期

关键词：

Anal carcinoma; FDG; PET/CT; Impact on management; POSITRON-EMISSION-TOMOGRAPHY; EPIDERMOID CARCINOMA; CANCER; CT; F-18-FDG; SURVIVAL; TUMORS; HIV-1;

D O I：

10.1016/j.mednuc.2009.12.005

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Purpose. To evaluate the impact of FDG PET/CT on the management of patients referred for the staging and/or the follow-up of anal carcinoma, and PET/CT on patient management. Patients and methods. We included patients referred to our department for anal carcinoma whose therapeutic management was evaluable thanks to follow-up data during at least 6 months. Results. Data of 44 patients were analysed: 22 had PET/CT for initial staging and 36 during follow-up. PET/CT had impact in nine patients out of 44 (20%) and it was relevant in eight of them. Conclusion. FDG PET/CT is an accurate imaging modality in anal cancer, its impact on patient management is more obvious when persistence or recurrence of disease is suspected. (C) 2009 Elsevier Masson SAS. Tous droits reserves.

引用

页码：96 / 102

页数：7

共 50 条

[21] Impact of FDG-PET/CT in the management of lymphoma
Baba, Shingo
Abe, Koichiro
Isoda, Takuro
Maruoka, Yasuhiro
Sasaki, Masayuki
Honda, Hiroshi
ANNALS OF NUCLEAR MEDICINE, 2011, 25 (10) : 701 - 716
[22] Impact of FDG-PET/CT in the management of lymphoma
Shingo Baba
Koichiro Abe
Takuro Isoda
Yasuhiro Maruoka
Masayuki Sasaki
Hiroshi Honda
Annals of Nuclear Medicine, 2011, 25 : 701 - 716
[23] FDG-PET in anal cancer: Impact on staging and radiotherapeutic management
Malyap, RS
Myerson, RJ
Dehdashti, F
Siegel, BA
Kodner, IJ
Fleshman, JW
Birnbaum, EH
Dietz, DW
Mutch, MG
Jennifer, LK
Abbey, EE
Picus, J
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S421 - S422
[24] The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer
Robertson, N. L.
Hricak, H.
Sonoda, Y.
Sosa, R. E.
Benz, M.
Lyons, G.
Abu-Rustum, N. R.
Sala, E.
Vargas, H. A.
GYNECOLOGIC ONCOLOGY, 2016, 140 (03) : 420 - 424
[25] FDG PET and PET/CT in the Management of Pediatric Lymphoma Patients
Cheng, Gang
Servaes, Sabah
Alavi, Abass
Zhuang, Hongming
PET CLINICS, 2008, 3 (04) : 621 - +
[26] Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up
Sachin S. Saboo
Katherine Zukotynski
Atul B. Shinagare
Katherine M. Krajewski
Nikhil Ramaiya
Abdominal Imaging, 2013, 38 : 728 - 735
[27] Role of 18F-FDG PET/CT in Posttreatment Evaluation of Anal Carcinoma
Houard, Clemence
Pinaquy, Jean-Baptiste
Mesguich, Charles
de Figueiredo, Benedicte Henriques
Cazeau, Anne-Laure
Allard, Jean-Baptiste
Laharie, Hortense
Bordenave, Laurence
Fernandez, Philippe
Vendrely, Veronique
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (09) : 1414 - 1420
[28] Impact of FDG PET/CT in management of recurrent breast carcinoma - Locoregional versus systemic treatment
Kuruva, Manohar
Karri, Raghava Kashyap
Mittal, Bhagwant
Bhattacharya, Anish
JOURNAL OF NUCLEAR MEDICINE, 2010, 51
[29] Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up
Saboo, Sachin S.
Zukotynski, Katherine
Shinagare, Atul B.
Krajewski, Katherine M.
Ramaiya, Nikhil
ABDOMINAL IMAGING, 2013, 38 (04): : 728 - 735
[30] Clinical Management in Patients with suspected Mycotic Aneurysms: Impact of FDG-PET/CT
Husmann, L.
Huellner, M. W.
Gruenig, H.
Eberhard, N.
Mestres, C. A.
Rancic, Z.
Hasse, B.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S122 - S122

← 1 2 3 4 5 →